Trial of Vitamin D in HIV Progression

PHASE3CompletedINTERVENTIONAL
Enrollment

4,000

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2019

Conditions
HIV Infection
Interventions
DIETARY_SUPPLEMENT

Vitamin D3 (cholecalciferol)

Supplements containing 50,000 IU of vitamin D3 (cholecalciferol) taken orally once per week for 4 weeks (weeks 0, 1, 2, 3) followed by 2,000 IU of vitamin D3 (cholecalciferol) supplements taken orally once per day starting at 4 weeks until study discharge at 12 months

OTHER

Placebo

Placebo pills taken once weekly for 4 weeks (weeks 0, 1, 2, 3) followed by placebo pills taken orally once per day starting at 4 weeks until study discharge at 12 months

Trial Locations (1)

Unknown

Management and Development for Health (MDH), Dar es Salaam

All Listed Sponsors
collaborator

Management and Development for Health (MDH)

UNKNOWN

lead

Harvard School of Public Health (HSPH)

OTHER

NCT01798680 - Trial of Vitamin D in HIV Progression | Biotech Hunter | Biotech Hunter